Jump to navigation
Data from the ongoing AZ HEROES study found that the COVID-19 vaccine is highly effective at preventing infection in Arizona teens.
Bacterial lysate OM-85 blocked SARS-CoV-2 infection by decreasing the coronavirus's ability to bind to the lung cell surface receptor ACE2, research found.
New research uncovered a way by which infections boost the production and function of naïve T cells, the body’s first line of defense against disease.
The NIH RECOVER Initiative aims to identify risks contributing to post-acute sequelae of SARS-CoV-2 infection, and approaches for treatment and prevention.
The Arizona Geriatrics Society honored Janko Nikolich-Žugich, MD, PhD, as the 2021 Gerontologist of the Year at its Annual Fall Symposium.
The antibody test developed at the UArizona Health Sciences can be used to confirm a positive antibody response after receiving a COVID-19 vaccine.
Using a highly accurate test they developed, University of Arizona Health Sciences researchers have shown that antibodies persist for months after infection.
The antibody test determines who has been exposed to and developed an immune response against COVID-19.
UArizona and Covid Watch Launch COVID-19 Exposure Notification App